S&P 500
(0.26%) 5 321.77 points
Dow Jones
(0.21%) 39 889 points
Nasdaq
(0.19%) 16 827 points
Oil
(-0.93%) $79.06
Gas
(-2.58%) $2.68
Gold
(-0.43%) $2 427.90
Silver
(-0.59%) $32.24
Platinum
(0.03%) $1 064.00
USD/EUR
(0.04%) $0.921
USD/NOK
(-0.29%) $10.67
USD/GBP
(-0.07%) $0.786
USD/RUB
(-0.40%) $90.32

实时更新: YS Biopharma Co., Ltd. [YS]

交易所: NASDAQ Capital Market 部门: Healthcare 工业: Biotechnology
最后更新时间22 May 2024 @ 03:37

-0.40% $ 0.973

Live Chart Being Loaded With Signals

Commentary (22 May 2024 @ 03:37):

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer...

Stats
今日成交量 47 348.00
平均成交量 176 429
市值 183.17M
EPS $0 ( 2024-04-19 )
下一个收益日期 ( $-0.0900 ) 2024-08-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.710
ATR14 $0.00700 (0.72%)

音量 相关性

長: -0.26 (neutral)
短: 0.41 (neutral)
Signal:(45.29) Neutral

YS Biopharma Co., Ltd. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

YS Biopharma Co., Ltd. 相关性 - 货币/商品

The country flag -0.11
( neutral )
The country flag -0.07
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.05
( neutral )

YS Biopharma Co., Ltd. 财务报表

Annual 2023
营收: $687.20M
毛利润: $533.84M (77.68 %)
EPS: $-1.560
FY 2023
营收: $687.20M
毛利润: $533.84M (77.68 %)
EPS: $-1.560
FY 2022
营收: $502.95M
毛利润: $385.88M (76.72 %)
EPS: $-1.150

Financial Reports:

No articles found.

YS Biopharma Co., Ltd. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

YS Biopharma Co., Ltd.

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。